ACTRN12613000738729招募中1 期
ebulised Heparin for Heart Surgery: A Randomised, Double-Blind, Placebo-Controlled Trial to evaluate the effect of nebulised heparin on PaO2/FiO2 in patients undergoing coronary artery bypass grafting (CABG)
适应症
试验速览
- 阶段
- 1 期
- 状态
- 招募中
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomised controlled trial
- 主要目的
- Prevention
- 盲法
- Blinded (masking used)
入排标准
- 年龄范围
- 18 Years 至 79 Years（—）
- 性别
- Male
入选标准
- •coronary artery bypass grafting (CABG) with 4 or more grafts
- •or a combined procedure of CABG with open aortic valve replacement.
排除标准
- •Allergy to heparin; any history of heparin induced thrombocytopenia
- •Renal impairment (defined as creatinine >130 umol/L)
- •Planned to receive pre-operative heparin
- •Receiving systemic immunosuppressant (such as steroids, cyclosporine, azathioprine)
- •Marked limitation of physical activity: defined as development of fatigue or shortness of breath on walking 100 meters.
研究者
相似试验
招募中
不适用
Heparin concentration after cardiac surgeryCardiovascular surgeryJPRN-UMIN000045103agoya University Hospital, Anesthesiology100
已完成
不适用
Heparin sensitivity in cardio-thoracic surgery: the effect of surgical traumacardiac valve surgeryCoronary artery bypass graft surgery10007593NL-OMON36891Vrije Universiteit Medisch Centrum78
已完成
不适用
Heparin Dose and Post Operative Bleeding in Cardiopulmonary Bypass PatientsCoronary Artery DiseaseNCT01574105University of Saskatchewan66
招募中
不适用
ebulized heparin in patients with mainly moderate coronavirus disease 2019: Randomized controlled trial. COVID-19COVID 19PACTR202007606032743Dr Tarek Ismail100
Unknown
不适用
When Heparin Stopped for Anticoagulation During ECMO DecannulationExtracorporeal Membrane OxygenationNCT05239637Second Affiliated Hospital of Zhengzhou University40